Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2010
10/13/2010CN101861304A New thrombin function compounds and pharmaceutical compositions based on them
10/13/2010CN101857579A Synthesis method of 2-amino-5,6-dichlorobenzothiazole
10/13/2010CN101857578A New crystal form of febuxostat and preparation method
10/12/2010US7812167 Substituted (thiazol-2-yl)-amides or sulfonamides as glucokinase activators useful in the treatment of type 2 diabetes
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812026 Imidazole derivatives having a positive allosteric GABAB receptor modulator effect and methods of use
10/12/2010CA2558585C Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/06/2010EP2236502A1 Sulfenamide, vulcanization accelerator containing the sulfenamide for rubber, and process for producing the same
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2236032A2 Herbicidal agent on the basis of heteroaryloxyacetamides
10/06/2010EP2236031A2 Herbicidal agent on the basis of heteroaryloxyacetamides
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2235008A2 Amide compounds as boosters of antivirals
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234954A1 Tetrasubstituted benzenes
10/06/2010EP1910325B1 New pharmaceutical compounds
10/06/2010EP1689726B1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
10/06/2010EP1537091B1 Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN101855213A Therapeutic compounds
10/06/2010CN101855212A Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
10/06/2010CN101851217A Synthesis method of (S)-2,6-diamino-4,5,6,7-tetrahydro benzothiazol
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
09/2010
09/30/2010WO2010111303A2 Imaging agents for detecting neurological disorders
09/30/2010WO2010110631A2 Benzopyran derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for preventing or treating inflammatory diseases containing same as an active ingredient
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010108856A1 Leukotriene b4 inhibitors
09/30/2010WO2010008831A3 Compounds and methods for modulating g protein-coupled receptors
09/30/2010US20100249427 Bioluminescent protease assay
09/30/2010US20100249424 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
09/30/2010US20100249404 Method for Carrying Out Chemical Reactions with the Aid of an Inductively Heated Heating Medium
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100248313 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010CA2756137A1 Imaging agents for detecting neurological disorders
09/30/2010CA2747327A1 Leukotriene b4 inhibitors
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231628A1 Inhibitors of cytochrome p450
09/29/2010EP2231627A2 New process for the synthesis of moguisteine
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010EP1313731B1 Thiazolidine derivatives and its use as antifungal agent
09/29/2010CN1934077B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101848901A Thiazolidinedione analogues for the treatment of hypertension
09/29/2010CN101848894A New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
09/29/2010CN101845027A N-substituted phenyl-benzothiazolone-3-formamide derivative
09/29/2010CN101845026A 5-(4-chlorophenylmethyl)-4-tertiary butyl thiazole derivatives and preparation method and application thereof
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
09/28/2010US7803797 Substituted arylcyclopentenes as therapeutic agents
09/28/2010US7803790 treating, reducing the frequency of or delaying the onset of pain comprising administering transient receptor potential vanilloid-3 (TRPV3 ) antagonists, such as 2-(6-Amino-benzothiazol-2-ylsulfanyl)-1-(3,4-dihydro-2H-quinolin-1-yl)-ethanone
09/28/2010CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
09/28/2010CA2420302C Catalytic process for the preparation of thiazole derivatives
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010108172A1 Crystalline tripeptide epoxy ketone protease inhibitors
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010106896A1 Luminescent substrate for luciferase which has controlled wavelength and process for producing same
09/23/2010US20100240903 Crystalline tripeptide epoxy ketone protease inhibitors
09/23/2010US20100240890 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
09/23/2010US20100240889 Urea Derivatives Methods For Their Manufacture And Uses Thereof
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/23/2010US20100240720 Allosteric jnk inhibitors
09/23/2010US20100240678 Leukotriene b4 inhibitors
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010CA2755971A1 Crystalline tripeptide epoxy ketone protease inhibitors
09/22/2010CN1658872B Antiallergic
09/22/2010CN101842362A Benzothiazole compounds
09/22/2010CN101838264A Compound, optical film and process for producing optical film
09/21/2010US7799929 Biotin intermediate and process for preparing the same
09/21/2010US7799927 optical recording media with said organic dye as recording layer; high density Disk-Recordable (HD DVD-R)
09/21/2010US7799814 Thiazole derivatives and use thereof
09/21/2010US7799813 Salts of substituted 5-membered azacycle and use thereof in the treatment of diseases related to protein aging
09/21/2010US7799808 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
09/21/2010US7799738 2-(3-Chlorobenzoyl)amino-N-(2,6-dimethyl-4-heptafluoro- isopropylphenyl)-1,3-thiazole-4-carboxamide; treating transgenic seeds and plants; sanitation; preservatives; alkali resistance; residue in wood
09/21/2010CA2590575C 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
09/21/2010CA2477720C Quinoline derivatives
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2411111C Thiazolyl, oxazolyl and pyrazolyl-substituted heterocycles and their use as pesticides and herbicides
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/16/2010WO2010105048A1 Thiazolidinedione analogues
09/16/2010WO2010104027A1 Thiazole derivative and process for producing same
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 337